Used in research to modulate immune responses by targeting interleukin-1 receptor-associated kinases, particularly in pathways linked to inflammation and autoimmune diseases. Shows potential in studies related to rheumatoid arthritis, lupus, and certain cancers where dysregulated signaling contributes to disease progression. Enables selective inhibition to help dissect signaling mechanisms in cellular models. Not approved for clinical use; primarily a tool compound in preclinical research.